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Previous studies have demonstrated that surface antigen proteins, in particular SAG-1, of Toxoplasma gondii
are important to this parasite as attachment ligands for the host cell. An in vitro assay was developed to test
whether these ligands and other secretory proteins are involved in the immune response of human cells to
toxoplasma. Human monocytes were infected with tachyzoites in the presence of antiparasite antibodies, and
their effect on mitogen-induced lymphoproliferation was examined. The presence of antibody to either parasiteexcreted proteins (MIC-1 and MIC-2) or surface proteins (SAG-1 and SAG-2) during infection neutralized the
marked decrease seen in mitogen-induced lymphoproliferation in the presence of infected monocytes. Conversely, antibodies to other secreted proteins (ROP-1) and cytoplasmic molecules had no effect on parasiteinduced, monocyte-mediated downregulation. Fluorescence microscope analysis detected microneme and surface antigen proteins on the monocyte cell surface during infection. These results suggest that microneme and
surface antigen proteins trigger monocytes to downregulate mitogen-induced lymphoproliferation.
could induce this immune system downregulatory response.
Since microneme proteins are secreted only by viable parasites
and since tachyzoite surface proteins can be heat denatured
and rendered nonimmunogenic, these proteins may be the
parasite ligands that trigger the release of the soluble factor(s)
involved in immune system downregulation by the parasite. To
investigate these hypotheses, we infected monocytes with tachyzoites in the presence of anti-MIC and anti-SAG antibodies
and examined the effect on the proliferative response of lymphocytes to mitogen. These studies suggest that the tachyzoite
proteins MIC-1, MIC-2, SAG-1, and SAG-2 can function as
ligands that trigger host cell signaling events culminating in
immune system downregulation.

Toxoplasmosis is the most common central nervous system
infection in patients with AIDS. As many as one-third of all
AIDS patients suffer from symptomatic disease, usually manifested as acute meningoencephalitis (10). The causative agent,
Toxoplasma gondii, is an obligate intracellular parasite that is
ingested by the host and invades the host intestinal cells. Parasite replication is dependent upon infection of host cells by
tachyzoites. During the initial stage of infection, tachyzoites
attach to and then actively penetrate the host cells to become
intracellular. Tachyzoite ligands known to play a role in attachment include the tachyzoite-specific major surface antigens,
SAG-1 (9, 15, 16), SAG-2 (9), and SAG-3 (3), and the microneme proteins. Micronemes are small apical organelles containing specific proteins that are found in variable amounts in
the invasive stages of all Apicomplexa. Micronemes are present in the tachyzoite stage of T. gondii, and three microneme
proteins, MIC-1, MIC-2, and MIC-3, have been identified (7).
MIC-2 is released from the micronemes during the attachment
phase of infection and is believed to insert as an extracellular
transmembrane protein at the apical pole of the tachyzoite
plasma membrane during the process of invasion. It has been
suggested that this protein attaches to host receptors and is
capped before formation of the parasitophorous vacuole and
released from the posterior end of the parasite (2). MIC-1 has
homology to the thrombospondin-related adhesive proteins of
Plasmodium knowlesi that have been shown to bind to human
hepatocytes (17), but the function of MIC-1 and MIC-3 in
T. gondii is unknown.
We have reported that lymphocytes show a marked decrease
in mitogen-induced lymphoproliferation in the presence of human peripheral blood monocytes that have been incubated in
vitro with tachyzoites (4). The downregulatory effect on lymphoproliferation was observed when monocytes were infected
with either viable parasites or parasites that had been irradiated, which rendered them infective but unable to replicate.
Neither heat-killed tachyzoites nor soluble parasite antigen

MATERIALS AND METHODS
Isolation of human monocytes and lymphocytes. Cells were obtained from
healthy toxoplasma-seronegative volunteers by cytophoresis. Mononuclear cells
were separated from whole blood by using Ficoll-Hypaque (Winthrop Laboratories, New York, N.Y.), and monocytes were 80 to 90% enriched by aggregation
as described previously (8). Platelets were removed from monocytes by washing
twice in Versene buffer (0.2 g of EDTA per liter in phosphate-buffered saline
[PBS]). Enriched monocytes were resuspended in medium (RPMI 1640 containing 25 mM HEPES buffer with L-glutamine) (Gibco Laboratories, Grand Island,
N.Y.) supplemented with gentamicin sulfate (50 mg/ml [United States Biochemical Corp., Cleveland, Ohio]) and 10% (vol/vol) heat-inactivated (56°C for 30
min) fetal bovine serum (endotoxin-low [HyClone Laboratories, Inc., Logan,
Utah]) and cultured overnight in tissue culture plates or on 12-mm-diameter
glass coverslips (100,000 monocytes/coverslip). Under these conditions, monocytes in tissue culture plates remain nonadherent. Cytocentrifuge (Shandon
Lipshaw, Pittsburgh, Pa.) preparations of monocytes (100,000 cells; 700 rpm for
5 min) were stained with Diff-Quik (Baxter Healthcare Corp., Miami, Fla.), and
the percentages of monocytes, lymphocytes, and neutrophils were determined by
microscopy. The remaining lymphocytes, enriched more than 90%, were resuspended at a density of 5 3 106/ml in medium and cultured in tissue culture flasks
until their use in assays 48 h later. Special care was taken to ensure endotoxinfree conditions in all experiments, as measured by the Limulus amebocyte assay
(Associates of Cape Cod, Falmouth, Mass.).
Parasites. T. gondii PLK was passaged in human fibroblasts maintained in
minimal essential medium (alpha modification; Gibco Laboratories) containing antibiotic-antimycotic solution (Gibco Laboratories) and isolated as decribed previously (11). Briefly, infected fibroblasts were scraped, forcibly passed
through a 27-gauge needle, and centrifuged at 50 3 g for 4 min to pellet large
host cell debris. The supernatant was centrifuged at 900 3 g for 10 min to pellet
the parasites, which were then resuspended in medium. The PLK strain is derived from the cloned P strain (Me49) and is regularly passaged in human foreskin fibroblasts in our laboratory.
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Monocyte triggering and lymphoproliferation assay. Monocytes were incubated for 18 h with parasites in the presence or absence of antiparasite antibodies.
Antibodies (10 mg/ml for purified immunoglobulin G (IgG); 1:200 dilution for
monoclonal antibody ascites) were added to monocytes 5 min before the addition
of parasites. Parasites and antibodies were not washed off, since monocytes remained nonadherent throughout each experiment. Since naive lymphocytes
respond poorly to specific antigen, the proliferative response of lymphocytes to
mitogen was examined. Lymphocytes (150,000/well) and mitogen (2 mg of phytohemagglutinin per ml [Pharmacia Biotech Inc., Piscataway, N.J.]) were added
to monocytes (2 3 104/well in a 96-well tissue culture plate) that had been incubated for 18 h with or without parasites. After a 24-h incubation with mitogen,
the cultures were pulsed for a further 24 h with [3H]thymidine (0.5 mCi per well
for a 96-well plate; 2 mCi per well for 24-well plate; 70 to 90 Ci/mmol [DuPont
NEN, Boston, Mass.]). The cells were harvested onto a glass filter with an automated cell harvester, and the isotope incorporation was measured by liquid scintillation counting. The mean value for three replicate cultures was determined and
used in calculations of lymphoproliferation. Lymphoproliferation is expressed as a
percentage of the response with uninfected monocytes (Dcpm of lymphocytes incubated with monocytes plus parasites/Dcpm of lymphocytes incubated with monocytes plus medium) 3 100, where Dcpm is the mean counts per minute in response to mitogen minus the mean counts per minute for unstimulated cultures.
Light microscopy. Monocytes (5 3 105/500 ml in wells of a 24-well tissue culture plate) and parasites were incubated together for 18 h. Antibody was added
to monocytes 5 min before the addition of parasites. Triplicate cytospin preparations (105 cells; 700 rpm for 5 min) were made for each sample. The cells were
fixed and stained with Diff-Quik, and the number of parasites per monocyte was
counted with a Zeiss Axiophot microscope. At least 200 cells were counted for each
cytospin. The results are expressed as a cumulative percentage of total monocytes.
Fluorescence microscopy. Monocytes adherent to a glass coverslip were incubated with tachyzoites at a monocyte-to-tachyzoite ratio of 1:25 for 1 h at 37°C.
Every 5 min, cells were washed extensively with ice-cold PBS to remove extracellular parasites. To determine the binding of parasite proteins to the monocyte
cell surface, cells were incubated on ice for 45 min with primary antibodies.
Either a mixture of anti-SAG-1 IgG (1 mg/ml) and anti-SAG-2 ascites (1:400
dilution), a mixture of anti-MIC-1, anti-MIC-2, and anti-MIC-3 ascites (1:400
dilution of each ascites), or isotype control antibodies were used, in the presence
of human IgG (400 mg/ml) to block nonspecific binding of antibodies to monocyte FcgRI. The cells were washed with PBS–0.1% bovine serum albumin (BSA)
and then incubated on ice for 45 min with a fluorescein isothiocyanate (FITC)conjugated secondary antibody (1:50 final concentration [Caltag Laboratories
Inc., South San Francisco, Calif.]). To stain cell nuclei, cells were incubated for
5 min on ice with propidium iodide in permeabilization buffer (0.3 mg of propidium iodide per ml in PBS–0.5% saponin [Sigma Chemical Co., St. Louis, Mo.]).
Finally, the cells were fixed with PBS containing 2.5% formaldehyde (ultrapure,
electron microscopy grade [Polysciences, Inc., Warrington, Pa.]) and 0.01%
glutaraldehyde (ultrapure, electron microscopy grade [Polysciences, Inc.]) for 10
min at room temperature. The cells were examined at 1,2503 magnification with
a Zeiss Axiophot epifluorescence microscope equipped with a 1003 1.3 N.A.
Plan Neofluar objective. Simultaneous examination of red-green fluorescence
was possible by using a dual-bandpass filter (Omega Optical, Brattleboro, Vt.;
green: excitation 490/20 nm, emission 528/24 nm; red: excitation 576/32 nm,
emission 633/42 nm). Images were recorded onto Kodak Elite 200 ASA slide film
and then onto prints.
Flow cytometry. Freshly isolated parasites (2 3 107/2 ml) were overlaid on a
Percoll gradient (5 ml of 1.04-g/ml Percoll [Pharmacia Biotech Inc.], and pelleted
by centrifugation (1,000 3 g for 10 min), leaving fibroblast debris above the
Percoll gradient. The parasites (106) were then incubated for 45 min at 4°C with
antibodies [rabbit anti-tachyzoite IgG, anti-tachyzoite F(ab9)2, anti-SAG-1, and
anti-low-density lipoprotein IgG, 1-mg/ml final concentration; mouse anti-SAG-2
ascites and P3 ascites, 1:200 dilution] in 50 ml of RPMI 1640 supplemented with
0.1% BSA (Sigma Chemical Co.) in 96-well flat-bottom tissue culture plates
(Costar Corp., Cambridge, Mass.). After the plates were washed three times with
PBS–0.1% BSA, the parasites were incubated for a further 45 min at 4°C in 60
ml of a 1:40 dilution (vol/vol) of FITC-conjugated anti-species IgG diluted in
PBS–0.1% BSA. After the plates were washed three times, more than 10,000
parasites per sample were analyzed in a FACScan flow cytometer (Becton Dickinson, San Jose, Calif.).
Antibodies. Mouse anti-MIC-1 (T10 1F7), anti-MIC-2 (T3 4A11), anti-MIC-3
(T4 2F3) ascites, anti-SAG-2 ascites, anti-p97 IgG, anti-ROP-1 IgG, and antiSAG-1 IgG were isolated and characterized as described previously (1, 5, 11, 12,
14, 18, 19). Rabbit anti-toxoplasma IgG and anti-toxoplasma F(ab9)2 fragments
were made in our laboratory. Rabbit anti-low density lipoprotein (anti-LDL), a
nonspecific rabbit polyclonal antibody was a generous gift of P. Morganelli,
Veterans Administration Hospital, White River Junction, Vt. P3, a nonspecific
ascites control, was made in our laboratory from a hybridoma provided by the
American Type Culture Collection. FITC-conjugated F(ab9)2 fragments of affinity-isolated anti-mouse IgG were obtained from Caltag Laboratories, and
FITC-conjugated F(ab9)2 fragments of affinity-isolated anti-rabbit IgG were from
Pierce, Rockford, Ill.
Statistics. Statistics for cpm data were analyzed by one-way analysis of variance with log-transformed data (6).
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FIG. 1. Anti-SAG antibodies block the effect of infected monocytes on lymphoproliferation and cause a decrease in the number of monocytes that become
infected with toxoplasmas. (A) Freshly isolated monocytes were incubated for
18 h with antibodies and parasites at a monocyte-to-parasite ratio of 1:2, and
then lymphocytes and mitogen were added for a further 48 h. Lymphoproliferation was determined as the mean and standard deviation of triplicate determinations of cpm, and the results are expressed as a percentage of the response
with uninfected monocytes. (B) Monocytes were incubated for 18 h with antibodies and parasites at a monocyte-to-parasite ratio of 1:2, and then cytospin
preparations were made for microscopy. The results are reported as the cumulative percentage of cells that were uninfected (u) or infected with one (`), two
(h), four (o), or eight (■) tachyzoites per vacuole and are representative of
three donors.

RESULTS
Anti-SAG-1 and anti-SAG-2 block the release of inhibitory
soluble factors from monocytes, and inhibit parasite uptake
into monocytes. When monocytes are infected with T. gondii,
soluble factors are released that markedly decrease mitogeninduced lymphoproliferation; this response is parasite dosedependent (4). To determine whether parasite surface antigens
may trigger the monocyte signal transduction pathway(s) leading to the release of these soluble factors, monocytes were
incubated with tachyzoites in the presence or absence of antiSAG antibodies. After an 18-h infection, the time at which
soluble-factor release is maximal (4), lymphocytes and mitogen
were added to infected monocytes. When lymphocytes were
incubated with uninfected monocytes, mitogen-induced lymphoproliferation was maximal and is identical to that seen in
the absence of monocytes. In contrast, when lymphocytes were
incubated with monocytes infected with tachyzoites at a 1:1
ratio, mitogen-induced lymphoproliferation was only 30%
of maximal. Identical results were obtained when an isotypematched control antibody was present during monocyte infection (Fig. 1A). With monocytes infected in the presence of
anti-SAG-1 or anti-SAG-2 antibodies, mitogen-induced lymphoproliferation was 76 or 62%, respectively, of that measured
in the presence of uninfected monocytes (Fig. 1A). When
monocytes were infected in the presence of both anti-SAG1 and anti-SAG-2, the decrease in lymphoproliferation was
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blocked completely. The antibodies alone had no effect on
mitogen-induced lymphoproliferation (data not shown). An
alternative explanation for our results is that engagement of
monocyte Fcg receptors by immune complexes formed between the antibodies and their ligands may signal a pathway
that decreases soluble factor release. This is unlikely since an
identical response occurred in the presence of anti-tachyzoite
F(ab9)2 fragments and anti-tachyzoite IgG (data not shown).
Tachyzoites were also incubated with the antibodies at the
same concentrations used for monocyte infection experiments,
stained, and examined with a FACScan apparatus. Each of the
specific antibodies directed at SAG-1, SAG-2, or whole parasites bound to tachyzoites with a mean fluorescence intensity of
.200, whereas the isotype-matched control antibody had an
intensity of ,20, showing that antiparasite antibodies recognize tachyzoite cell surface antigens (data not shown).
In the absence of attachment, host cell surface receptors
leading to soluble-factor release may not be triggered. To
determine the effect of anti-SAG antibodies on attachment, we
also determined tachyzoite uptake and replication. The maximal permissiveness of monocytes for tachyzoite uptake and
replication was seen when monocytes were infected in the
presence of an isotype-matched control antibody. After an
18-h infection, 6% of all monocytes were uninfected, 4% contained a parasitophorous vacuole with one tachyzoite, 10%
contained a vacuole with two tachyzoites, 23% contained a
vacuole with four tachyzoites, and 57% contained a vacuole
with eight tachyzoites (Fig. 1B). The effect of either antibody
reduced the level of infectivity of the monocytes compared to
the irrelevant antibody control. When these antibodies were
combined, the blocking effect was enhanced (Fig. 1B). For
example, after an 18-h infection in the presence of both antiSAG-1 and anti-SAG-2, 55% of all monocytes were uninfected, 9% contained a parasitophorous vacuole with one tachyzoite, 13% contained a vacuole with two tachyzoites, 16%
contained a vacuole with four tachyzoites, and 7% contained a
vacuole with eight tachyzoites. Although the majority of the
monocytes (55%) were uninfected following treatment with
both anti-SAG-1 and anti-SAG-2, the decrease in lymphoproliferation was ablated.
Anti-MIC-1 and anti-MIC-2 block the release of inhibitory
soluble factors from monocytes and inhibit parasite uptake
into monocytes. To determine whether parasite microneme
antigens may trigger the monocyte signal transduction pathway(s) leading to the release of inhibitory soluble factors,
monocytes were incubated with tachyzoites for 18 h in the
presence of anti-MIC antibodies and then added to a lymphocyte proliferation assay in response to mitogen. When lymphocytes were incubated with monocytes infected with tachyzoites
in the presence of an isotype-matched control antibody, mitogen-induced lymphoproliferation was 40% of the lymphoproliferation in the presence of uninfected monocytes (Fig. 2A).
When either anti-MIC-1 or anti-MIC-2 antibody was added
to monocytes before the addition of parasites, the decrease in
mitogen-induced lymphoproliferation was ablated. With antiMIC-3, mitogen-induced lymphoproliferation was 66% of the
level seen with uninfected monocytes. To determine if this was
a ligand-specific event, antibodies to another secreted protein,
ROP-1, or cytoplasmic protein, p97, were evaluated. Neither
anti-ROP-1 nor anti-p97 demonstrated an effect on neutralizing the downregulatory response (data not shown). The effect
of anti-MIC antibody on parasite internalization and replication was further evaluated. As shown in Fig. 2B, by 18 h after
infection in the presence of anti-MIC-2, 46% of all monocytes
were uninfected, 24% of the monocytes contained a parasitophorous vacuole with one tachyzoite, 17% contained a vacuole
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FIG. 2. Anti-MIC antibodies block the effect of infected monocytes on lymphoproliferation and cause a decrease in the number of monocytes that become
infected with toxoplasmas. (A) Freshly isolated monocytes were incubated for
18 h with antibodies and parasites at a monocyte-to-parasite ratio of 1:2, and
then lymphocytes and mitogen were added for a further 48 h. Lymphoproliferation was determined as the mean and standard deviation of triplicate determinations of cpm, and the results are expressed as a percentage of the response
with uninfected monocytes. (B) Monocytes were incubated for 18 h with antibodies and parasites at a monocyte-to-parasite ratio of 1:2, and then cytospin
preparations were made for microscopy. The results are reported as the cumulative percentage of cells that were uninfected (u) or infected with one (`), two
(h), four (o), or eight (■) tachyzoites per vacuole and are representative of
three donors.

with two tachyzoites, 11% contained a vacuole with four tachyzoites, and 2% contained a vacuole with eight tachyzoites.
Baseline 18-h infection in the presence of an isotype-matched
control antibody was 10% of all monocytes uninfected, 9% of
all monocytes containing a parasitophorous vacuole with one
tachyzoite, 12% containing a vacuole with two tachyzoites,
21% containing a vacuole with four tachyzoites, and 48% containing a vacuole with eight tachyzoites. The blocking effect of
the antibodies was concentration dependent (data not shown).
To determine whether the blocking effect of the antibodies
was additive for the different parasite ligands, combinations of
anti-SAG and anti-MIC antibodies were assayed. As was seen
when single antibodies were used, incubation of monocytes
and either anti-SAG-1 or anti-SAG-2 in the presence of antiMIC-2 resulted in the reversal of the downregulatory effect
compared to isotype-matched irrelevant control antibody (data
not shown). However, the combination of these antibodies inhibited parasite uptake and replication more than did single
antibodies alone (compare Fig. 3 with Fig. 1B and 2B). Mitogen-induced lymphoproliferation assayed in the absence of
monocytes was not affected by the presence of any antitoxoplasma antibody (data not shown). These results suggest that
anti-SAG and anti-MIC antibodies block the interaction of
parasite ligands with monocyte receptors.
It is possible that a critical level of infection of monocytes is
required to stimulate soluble-factor release. However, when
monocytes were infected with fewer parasites, resulting in a
15% monocyte infection level, mitogen-induced lymphoprolif-
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that the interaction between infected monocytes and antibody
is specific.

FIG. 3. Anti-SAG and anti-MIC antibodies cause a decrease in the number
of monocytes that become infected with toxoplasmas. Monocytes were incubated
for 18 h with antibodies and parasites at a monocyte-to-parasite ratio of 1:2, and
then cytospin preparations were made for microscopy. The results are reported
as the cumulative percentage of cells that were uninfected (u), or infected with
one (`), two (h), four (o), or eight (■) tachyzoites per vacuole and are representative of three donors.

eration remained suppressed (68% of the response compared
to uninfected monocytes), indicating that a 50% or better
threshold of infection for induction of a downregulatory response was not required.
SAG and MIC are deposited on the surface of monocytes
during infection. The binding of SAG and MIC proteins to
monocyte cell surface receptors during infection was evaluated. Monocytes were infected with tachyzoites at a high multiplicity of infection (1:25), and unfixed monocytes were surface
stained with mixtures of anti-SAG, anti-MIC, or isotypematched control antibodies followed by FITC-conjugated secondary antibodies for detection by fluorescence microscopy.
After a 15-min incubation with tachyzoites, the time required
for parasites to settle onto cells, fluorescent antibody to SAG
was observed in discrete patches on the surface of 10 to 15% of
the monocytes. The greatest binding appeared to occur close to
where a tachyzoite was attached (Fig. 4A). In contrast, only
background binding of isotype control antibodies to infected
monocytes was noted (Fig. 4B). For anti-MIC antibodies, the
kinetics of binding to the surface of 10 to 15% of monocytes
was similar. In general, fewer patches were observed compared
to the situation for anti-SAG antibodies. We found that antiSAG antibody binding could be competitively inhibited by soluble tachyzoite antigen and that the antibody did not bind to
uninfected monocytes (data not shown). These results show

DISCUSSION
Our results show that there are specific parasite proteins, in
particular the surface antigens SAG-1 and SAG-2 as well as the
secreted microneme proteins, that are essential to the stimulation of human monocytes. Antibodies to these specific parasite ligands can block the production of a soluble factor,
produced by human monocytes when infected with tachyzoites,
that mediates a decrease in mitogen-induced lymphocyte proliferation (4).
The sequence of events during the process of active penetration includes attachment via the major surface ligand,
SAG-1, followed by the immediate release of microneme proteins. Upon entry into the host cell, the parasitophorous vacuole forms as the parasite begins to actively penetrate the host
cell (2). In our present studies, when SAG-1 and SAG-2 were
blocked together, soluble-factor release was abrogated while
the number of monocytes infected was reduced from 94 to
45%. We show, both here and previously (4), that release of
soluble factors from infected monocytes persists below a 45%
level of infection. It is unlikely that the remaining infected
monocytes represent a population that had phagocytosed tachyzoites, since the majority of these cells contain replicating
tachyzoites and fusion of tachyzoite-containing phagosomes
with endosomes would result in phagosome acidification, an
event known to cause parasite death (20). These results suggest
that SAG-1 and SAG-2 are critical ligands in soluble-factor
triggering but that other surface ligands may be involved in
attachment. In this regard, a family of SAG-1-like surface
antigens, SRS (SAG-related sequence), have recently been
described (13). Blocking either MIC-1 or MIC-2 also abrogates
the release of soluble factors from monocytes and inhibits
parasite internalization. MIC-3 has a minor effect on both
processes. An alternative explanation for our results is that
engagement of monocyte Fcg receptors by immune complexes
formed between the antibodies and their ligands may signal a
pathway that decreases soluble-factor release. This is unlikely
since an identical response occurred in the presence of antitachyzoite F(ab9)2 fragments and anti-tachyzoite IgG (data not
shown). Our results with anti-SAG-1, anti-SAG-2, and antiMIC-3 may be explained if these antibodies were not present

FIG. 4. Anti-SAG antibodies bind to the surface of infected monocytes. Adherent monocytes were incubated with tachyzoites at a monocyte-to-tachyzoite ratio of
1:25, and every 5 min unfixed monocytes were stained with mixtures of anti-SAG-1 and anti-SAG-2 antibodies (A) or isotype-matched control antibodies (B) followed
by a FITC-conjugated secondary antibody and propidium iodide (in permeabilization buffer) for visualization by fluorescence microscopy. Anti-SAG but not control
antibodies bound to the surface of tachyzoites (arrows) and in discrete patches to the surface of monocytes (arrowheads). Propidium iodide stains monocyte and parasite
nuclei red. Bar, 2 mm. The results are representative of two donors.
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in saturating concentrations. This is unlikely for SAG-1 and
SAG-2, since FACScan analysis shows that the antibodies were
present at two- to fivefold the concentration required for maximal fluorescence (data not shown).
These results suggest a new role for microneme and surface
antigen proteins, namely, that they are parasite ligands that
engage host cell receptors that trigger the pathway(s) resulting
in the release of soluble factors. In support of this concept,
microneme and surface antigen proteins were detected by fluorescence microscopy on the surface of monocytes following
infection, suggesting that these proteins may be shed from the
parasite during uptake. This would imply that receptor-ligand
binding events are not confined to the immediate area of
parasite attachment but may occur over a greater surface area
of the host cell membrane. Since blocking either SAG ligands
or MIC ligands abrogates soluble-factor release, it is possible
that there is a single receptor for SAG or MIC ligands that
requires the binding of both ligands before signal transduction
occurs. Alternatively, it is possible that there are at least two
receptors that form a complex, which also requires both ligands
to be bound before signal transduction occurs. Studies to identify the monocyte receptors for SAG-1 or the microneme proteins are under way.
In summary, we suggest that SAG-1, SAG-2, MIC-1, and
MIC-2 are parasite ligands that engage the monocyte receptor(s) that triggers the signal transduction pathway(s) leading
to stimulation of the monocytes. Hence, only viable, intact
parasites that can release microneme proteins following attachment of surface antigen proteins to monocytes can provide
this trigger. This explains our previous results showing that
monocytes incubated with heat-denatured parasites had no
effect on mitogen-induced lymphoproliferation although live
and irradiated parasites, both of which can release microneme
proteins upon attachment, were effective triggers (4).
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